Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-082773
Filing Date
2025-06-06
Accepted
2025-06-06 11:29:01
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3784
  Complete submission text file 0000950170-25-082773.txt   5233
Mailing Address C/O MEDIMMUNE, INC. ONE MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address
Mathers Edward T (Reporting) CIK: 0001328625 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42272 | Film No.: 251029447

Mailing Address 11711 N. MERIDIAN STREET SUITE 300 CARMEL IN 46032
Business Address 11711 N. MERIDIAN STREET SUITE 300 CARMEL IN 46032 3179893100
MBX Biosciences, Inc. (Issuer) CIK: 0001776111 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)